Global Response To COVID-19 Promises Equitable Access, Independent WHO Probe
US Supports WHA’s COVID-19 Resolution, With Caveats
Executive Summary
A resolution at the latest World Health Assembly meeting on providing universal and equitable access to COVID-19 technologies, medicines and vaccines has been adopted, along with an agreement to review the World Health Organization’s response to the crisis.
You may also be interested in...
EU Urges Free Access To Publicly Funded COVID-19 Research Results
A “manifesto” to encourage the wider dissemination of COVID-19 research is the latest in a series of EU and international initiatives to quickly find treatments, vaccines and tests for the coronavirus.
WHO ‘Showed Leadership’ In Dealing With COVID-19, Says Interim Inquiry
An interim independent assessment of the WHO’s response to the COVID-19 pandemic has supported the organization’s work. But will be it enough to convince critics as the WHO faces the threat of permanently losing funds from its biggest donor, the US?
Should Pharma Release IP For COVID-19 Research? Novartis Exec Weighs In
As World Health Assembly prepares resolution for voluntary pooling and licensing, Novartis global head of IP Corey Salsberg discusses how intellectual property is advancing development of therapeutics and vaccines and the benefits of voluntary rather than compulsory licensing;